Ensaio clínico

MagDI Canada Study

NCT: NCT06467955 · ACTIVE_NOT_RECRUITING

ID NCTNCT06467955

EstadoACTIVE_NOT_RECRUITING

Data de início2024-05-10

SponsorGT Metabolic Solutions, Inc. (INDUSTRY)

First posted2024-06-21

Last updated2026-05-20

Resumo breve

The objective of the MagDI Canada study is to evaluate the performance and safety of the MagDI System in eligible participants who are indicated for a duodeno-ileal (small bowel) side-to-side anastomosis procedure for partial intestinal diversion as one example of a small bowel clinical procedure requiring a side-to-side anastomosis. The secondary objective includes initial efficacy of the duodeno-ileal diversion using the MagDI System.

Fonte oficial

Ver no ClinicalTrials.gov →

Dados provenientes da API do ClinicalTrials.gov. Para consultar o estado mais recente, veja o registo oficial.